We are live on ! Find out more
AC

Athos Capital Portfolio holdings

AUM $282M
1-Year Est. Return 11.4%
This Fund
S&P 500
This Quarter Est. Return
-8.36%
1 Year Est. Return
+11.4%
3 Year Est. Return
+109.86%
5 Year Est. Return
+194.68%
10 Year Est. Return
AUM
$128M
AUM Growth
-$17.1M
Cap. Flow
-$47.4M
Cap. Flow %
-36.97%
Top 10 Hldgs %
50.52%
Holding
100
New
14
Increased
2
Reduced
4
Closed
34

Sector Composition

Rank Sector Weight
1 Miscellaneous 63.32%
2 Healthcare 12.27%
3 Financials 11.94%
4 Technology 5.54%
5 Materials 2.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIMO icon
1
CALL
Silicon Motion
SIMO
$8.05B
$10.8M 8.41%
+150,000
New +$9.59M
HHLA.WS
2
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$8.45M 6.59%
806,349
ISEE
3
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$7.87M 6.14%
+200,000
New +$7.06M
TSEM icon
4
CALL
Tower Semiconductor
TSEM
$21.8B
$7.5M 5.86%
+200,000
New +$8.27M
SGEN
5
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
$5.77M 4.51%
+30,000
New +$5.96M
LFACW
6
DELISTED
LF Capital Acquisition Corp. II Warrants
LFACW
$5.34M 4.17%
500,000
HZNP
7
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.14M 4.01%
+50,000
New +$5.28M
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.9M 3.82%
47,600
-12,400
-21% -$1.31M
SGEN
9
DELISTED
Seagen Inc. Common Stock
SGEN
$4.71M 3.68%
24,500
-6,500
-21% -$1.29M
RENE
10
DELISTED
Cartesian Growth Corp II
RENE
$4.27M 3.33%
400,000
ATVI
11
CALL
DELISTED
Activision Blizzard
ATVI
$4.21M 3.29%
50,000
BSAQ
12
DELISTED
Black Spade Acquisition Co
BSAQ
$4.01M 3.13%
388,000
GMED icon
13
Globus Medical
GMED
$10B
$3.52M 2.75%
+59,200
New +$3.37M
UNVR
14
DELISTED
Univar Solutions Inc.
UNVR
$3.47M 2.71%
96,900
+1,900
+2% +$67.5K
VMW
15
DELISTED
VMware, Inc
VMW
$3.38M 2.64%
23,500
-6,500
-22% -$843K
RPD icon
16
Rapid7
RPD
$845M
$3.08M 2.4%
+67,900
New +$3.15M
CHEA
17
DELISTED
Chenghe Acquisition Co. Class A Ordinary Share
CHEA
$2.67M 2.09%
250,000
GRND.WS
18
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$2.51M 1.96%
454,651
DEN
19
DELISTED
Denbury Inc.
DEN
$2.18M 1.7%
+25,300
New +$2.29M
BSAQ.WS
20
DELISTED
Black Spade Acquisition Co Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BSAQ.WS
$2.01M 1.57%
193,999
BBIO icon
21
CALL
BridgeBio Pharma
BBIO
$13.4B
$1.72M 1.34%
+100,000
New +$1.5M
SYNH
22
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$1.67M 1.3%
+39,600
New +$1.6M
AJRD
23
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$1.52M 1.19%
27,800
+22,800
+456% +$1.27M
SHUAW
24
DELISTED
SHUAA Partners Acquisition Corp I Warrant
SHUAW
$1.48M 1.15%
137,499
AILEW
25
DELISTED
iLearningEngines, Inc. Warrant
AILEW
$1.46M 1.14%
139,999

Similar funds

Athos Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Athos Capital held 100 positions worth $128M, down 12% from $145M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Athos Capital withdrew a net $47.4M in Q2 2023, closing 34 positions and reducing 4 holdings. Its most notable exit was HH&L Acquisition Co., an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 63% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Athos Capital opened a new position in Globus Medical worth $3.52M.

  • Athos Capital's largest Q2 2023 buy was Globus Medical: 59,200 shares worth $3.52M.
  • Athos Capital added most to Aerojet Rocketdyne Holdings in Q2 2023, an estimated $1.27M increase.
  • Athos Capital's biggest Q2 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $1.31M.
  • Athos Capital fully exited HH&L Acquisition Co. in Q2 2023, selling an estimated $16.7M.
  • Athos Capital's ten largest holdings make up 51% of its $128M portfolio in Q2 2023.
  • Athos Capital opened 14 new positions and closed 34 in Q2 2023.
  • Athos Capital's portfolio value fell 12% quarter-over-quarter to $128M.

Based on Athos Capital's 13F filing for Q2 2023, filed 14 Aug 2023.